Peptides DB
Research-centric peptide and protocol reference hub

KPV vs NAD+

Updated July 27, 2026 · Reviewed by the PeptidesDB Editorial team

KPV: Research use — not FDA-approvedNAD+: Research use — not FDA-approved

A data-driven comparison of KPV and NAD+ (also searched as NAD+ vs KPV) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.

Verdict

KPV centers on inflammation, while NAD+ leans toward metabolic. On indexed research, KPV is ahead (KPV: 6 studies, Human evidence; NAD+: 5, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.

Key takeaways

  • KPV is strongest for inflammation; NAD+ for metabolic.
  • Evidence: KPV Human evidence (6 studies) vs NAD+ Human evidence (5).
  • Both are research-use compounds — not FDA-approved.

Effect profiles, overlaid

KPV: Healing 4.0, Muscle 0.0, Metabolic 0.0, Neuro 0.0, Sleep 0.0, Immune 5.0, Skin 0.0 — NAD+: Healing 3.0, Muscle 2.0, Metabolic 4.0, Neuro 3.0, Sleep 1.0, Immune 3.0, Skin 2.0Healing & recovery — 4.0 / 5 · KPVInflammation & immune — 5.0 / 5 · KPVHealing & recovery — 3.0 / 5 · NAD+Muscle & body comp — 2.0 / 5 · NAD+Metabolic & appetite — 4.0 / 5 · NAD+Neuro & mood — 3.0 / 5 · NAD+Sleep & circadian — 1.0 / 5 · NAD+Inflammation & immune — 3.0 / 5 · NAD+Skin & aesthetics — 2.0 / 5 · NAD+HealingMuscleMetabolicNeuroSleepImmuneSkin
KPVNAD+

At a glance

KPVHuman evidence

Anti-Inflammatory Tripeptide | Alpha-MSH Fragment

Strongest: InflammationStudies: 6Level: Emerging
NAD+Human evidence
Strongest: MetabolicStudies: 5Level:

KPV vs NAD+: side-by-side

MetricKPVNAD+
ClassImmune
Regulatory statusResearch use onlyResearch use only
Evidence gradeHuman evidenceHuman evidence
Studies indexed65
Research levelEmerging
Strongest effectInflammation & immuneMetabolic & appetite
Healing & recovery4.03.0
Muscle & body comp0.02.0
Metabolic & appetite0.04.0
Neuro & mood0.03.0
Sleep & circadian0.01.0
Inflammation & immune5.03.0
Skin & aesthetics0.02.0

▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).

Mechanism & pharmacokinetics

PropertyKPVNAD+
MechanismInteractions with immune cells, enhancing anti-inflammatory responsesElectron carrier in redox reactions

Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.

What is KPV?

### KPV Summary KPV is a tripeptide composed of lysine, proline, and valine, which has garnered interest in research for its potential roles in modulating immune responses and promoting wound healing. Its implications in various therapeutic contexts, particularly in inflammatory conditions, are currently being explored.

Full KPV profile, mechanism & studies →

What is NAD+?

### Summary NAD+ (Nicotinamide adenine dinucleotide) is a crucial coenzyme involved in various metabolic processes, including energy production and cellular repair mechanisms. Recent research highlights its potential roles in protecting against oxidative stress and enhancing therapeutic efficacy in certain cancer treatments.

Full NAD+ profile, mechanism & studies →

Which is better for your goal?

GoalBetter fitWhy
HealingKPV4.0/5 effect signal
MuscleNAD+2.0/5 effect signal
MetabolicNAD+4.0/5 effect signal
NeuroNAD+3.0/5 effect signal
SleepNAD+1.0/5 effect signal
InflammationKPV5.0/5 effect signal
SkinNAD+2.0/5 effect signal

Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.

Can you stack KPV and NAD+?

People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.

KPV vs NAD+: side effects

KPV

No community-reported effects logged yet.

NAD+

No community-reported effects logged yet.

Anonymous community reports (count = number of reports), not clinical incidence rates.

What the research says

KPV has 6 approved studies indexed (Human evidence), and NAD+ has 5 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.

Frequently asked questions

Is KPV or NAD+ better?

It depends on your goal. KPV is strongest for inflammation; NAD+ for metabolic. KPV has more indexed studies (6). See the goal-by-goal breakdown above.

Is KPV or NAD+ better for weight loss?

NAD+ shows the stronger metabolic & appetite profile (4.0/5) in the AI-assigned effect profile — though weight-loss outcomes depend on the individual and the evidence base.

Is KPV or NAD+ better for muscle?

NAD+ leads on the muscle & body-composition axis (2.0/5).

Which has more research, KPV or NAD+?

KPV has 6 approved studies indexed (Human evidence); NAD+ has 5 (Human evidence). Higher counts mean more to read, not proven superiority.

Can you stack KPV and NAD+?

Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.

What are the side effects of KPV vs NAD+?

KPV: no community-reported effects logged yet. NAD+: none logged yet. These are anonymous reports, not incidence rates — see each profile.

Is KPV or NAD+ FDA-approved?

KPV is a research-use compound and is not FDA-approved. NAD+ is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.

Is NAD+ better than KPV?

For metabolic, NAD+ has the edge; for inflammation, KPV does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.

Comparing related peptides

Regulatory & legal status

KPV and NAD+ are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 27, 2026.